Literature DB >> 14676206

Anthracyclines induce calpain-dependent titin proteolysis and necrosis in cardiomyocytes.

Chee Chew Lim1, Christian Zuppinger, Xinxin Guo, Gabriela M Kuster, Michiel Helmes, Hans M Eppenberger, Thomas M Suter, Ronglih Liao, Douglas B Sawyer.   

Abstract

Titin, the largest myofilament protein, serves as a template for sarcomere assembly and acts as a molecular spring to contribute to diastolic function. Titin is known to be extremely susceptible to calcium-dependent protease degradation in vitro. We hypothesized that titin degradation is an early event in doxorubicin-induced cardiac injury and that titin degradation occurs by activation of the calcium-dependent proteases, the calpains. Treatment of cultured adult rat cardiomyocytes with 1 or 3 micromol/liter doxorubicin for 24 h resulted in degradation of titin in myocyte lysates, which was confirmed by a reduction in immunostaining of an antibody to the spring-like (PEVK) domain of titin at the I-band of the sarcomere. The elastic domain of titin appears to be most susceptible to proteolysis because co-immunostaining with an antibody to titin at the M-line was preserved, suggesting targeted proteolysis of the spring-like domain of titin. Doxorubicin treatment for 1 h resulted in approximately 3-fold increase in calpain activity, which remained elevated at 48 h. Co-treatment with calpain inhibitors resulted in preservation of titin, reduction in myofibrillar disarray, and attenuation of cardiomyocyte necrosis but not apoptosis. Co-treatment with a caspase inhibitor did not prevent the degradation of titin, which precludes caspase-3 as an early mechanism of titin proteolysis. We conclude that calpain activation is an early event after doxorubicin treatment in cardiomyocytes and appears to target the degradation of titin. Proteolysis of the spring-like domain of titin may predispose cardiomyocytes to diastolic dysfunction, myofilament instability, and cell death by necrosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14676206     DOI: 10.1074/jbc.M308033200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  97 in total

Review 1.  Mechanisms of anthracycline cardiac injury: can we identify strategies for cardioprotection?

Authors:  Douglas B Sawyer; Xuyang Peng; Billy Chen; Laura Pentassuglia; Chee Chew Lim
Journal:  Prog Cardiovasc Dis       Date:  2010 Sep-Oct       Impact factor: 8.194

2.  Differential activation of natriuretic peptide receptors modulates cardiomyocyte proliferation during development.

Authors:  Jason R Becker; Sneha Chatterjee; Tamara Y Robinson; Jeffrey S Bennett; Daniela Panáková; Cristi L Galindo; Lin Zhong; Jordan T Shin; Shannon M Coy; Amy E Kelly; Dan M Roden; Chee Chew Lim; Calum A MacRae
Journal:  Development       Date:  2013-12-18       Impact factor: 6.868

Review 3.  Modulation of anthracycline-induced cardiotoxicity by aerobic exercise in breast cancer: current evidence and underlying mechanisms.

Authors:  Jessica M Scott; Aarif Khakoo; John R Mackey; Mark J Haykowsky; Pamela S Douglas; Lee W Jones
Journal:  Circulation       Date:  2011-08-02       Impact factor: 29.690

4.  Titin is a target of matrix metalloproteinase-2: implications in myocardial ischemia/reperfusion injury.

Authors:  Mohammad A M Ali; Woo Jung Cho; Bryan Hudson; Zamaneh Kassiri; Henk Granzier; Richard Schulz
Journal:  Circulation       Date:  2010-11-01       Impact factor: 29.690

5.  Increased mitochondrial emission of reactive oxygen species and calpain activation are required for doxorubicin-induced cardiac and skeletal muscle myopathy.

Authors:  Kisuk Min; Oh-Sung Kwon; Ashley J Smuder; Michael P Wiggs; Kurt J Sollanek; Demetra D Christou; Jeung-Ki Yoo; Moon-Hyon Hwang; Hazel H Szeto; Andreas N Kavazis; Scott K Powers
Journal:  J Physiol       Date:  2015-02-23       Impact factor: 5.182

Review 6.  Titin: physiological function and role in cardiomyopathy and failure.

Authors:  Henk Granzier; Yiming Wu; Labeit Siegfried; Martin LeWinter
Journal:  Heart Fail Rev       Date:  2005-09       Impact factor: 4.214

Review 7.  Calpain activity and muscle wasting in sepsis.

Authors:  Ira J Smith; Stewart H Lecker; Per-Olof Hasselgren
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-05-20       Impact factor: 4.310

Review 8.  The role of Neuregulin-1beta/ErbB signaling in the heart.

Authors:  Laura Pentassuglia; Douglas B Sawyer
Journal:  Exp Cell Res       Date:  2008-09-03       Impact factor: 3.905

9.  Anthracycline cardiotoxicity: from bench to bedside.

Authors:  Luca Gianni; Eugene H Herman; Steven E Lipshultz; Giorgio Minotti; Narine Sarvazyan; Douglas B Sawyer
Journal:  J Clin Oncol       Date:  2008-08-01       Impact factor: 44.544

10.  Transcription factor GATA4 inhibits doxorubicin-induced autophagy and cardiomyocyte death.

Authors:  Satoru Kobayashi; Paul Volden; Derek Timm; Kai Mao; Xianmin Xu; Qiangrong Liang
Journal:  J Biol Chem       Date:  2009-11-09       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.